Bastiano Sanna, EVP, Cell & Genetic Therapies at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,686 shares at $218.83 ($586K) on 2021-05-03, disclosed to the SEC on 2021-05-05.
Open-market sale of $586k VRTX by EVP, Cell & Genetic Therapies. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $217.21 | 766 | $166K | 28.4% |
| 2 | $218.06 | 501 | $109K | 18.7% |
| 3 | $218.06 | 501 | $109K | 18.7% |
| 4 | $218.83 | 459 | $100K | 17.1% |
| 5 | $218.83 | 459 | $100K | 17.1% |
| Total | $218.08 avg | 2,686 |
| $586K |
| 100% |
| Filing → |
| VRTX | SELL | 2023-04-14 | $4.9M | — | Filing → |
| VRTX | SELL | 2023-04-06 | $231K | — | Filing → |
| VRTX | SELL | 2023-03-20 | $1.7M | — | Filing → |